Gnosis by Lesaffre

This executive summary reviews the VitaK-CAC trial, which tested whether daily MK-7 supplementation could slow coronary artery calcification in adults with symptomatic coronary artery disease. Lacey Hall, MS, of Gnosis by Lesaffre covers the vitamin K2 biology behind the study, its 2-year results with MenaQ7®, and what the findings mean for formulators.

This executive summary examines how consumer demand for mobility and active aging is reshaping the joint health supplement category, and how MyCondro™, a fermentation-derived, non-animal chondroitin sulfate, addresses challenges with raw material variability, traceability, and sustainability. It reviews the role of chondroitin sulfate in cartilage biology, pharmacokinetic data showing greater plasma concentration than animal-derived chondroitin, and two randomized, placebo-controlled trials conducted at 600 mg daily. It also outlines practical formulation and brand positioning considerations for product developers.

Improved bioavailability enhances the absorption and utilization of an active ingredient, such as Quatrefolic®, helping maximize its nutritional potential. Explore this infographic to understand why bioavailability is a cornerstone of nutraceutical innovation.

Review the latest scientific evidence on the role of 5-MTHF, such as Quatrefolic®, in brain function, cognitive performance, and healthy aging, offering valuable insights for next-generation nutraceutical solutions.

Did you know how 5-MTHF, such as Quatrefolic®, supports key metabolic pathways involved in neurotransmitter production and homocysteine metabolism? This video explains the impact on mood health, as well as why are both essential for maintaining emotional well-being.

Explore the role of 5-MTHF in supporting cardiovascular health through optimal homocysteine metabolism. Backed by scientific evidence, the brochure provides insights into the benefits of Quatrefolic® active folate and its potential applications in innovative nutraceutical formulations.

Discover in this brochure all the features of MyCondro™: superior quality, excellent purity. MyCondro™ is also clinically validated to support joint health at low dose.

Explore this white paper to discover all the science on MyCondro™. This next-gen chondroitin sulfate offers superior bioavailability, excellent quality, and purity. MyCondro™ is clinically validated to support joint health and improved mobility.

Discover in this infographic the benefits of MyCondro™ vs the animal-derived chondroitin sulfate.

Brochure highlighting all the features of MyCondro™ the world’s first non-animal chondroitin sulfate from fermentation. This innovative ingredient supports mobility and joint health.